Functional skeletal muscle model derived from SOD1-mutant ALS patient iPSCs recapitulates hallmarks of disease progression

• Published in: Scientific reports Vol. 10; no. 1; p. 14302
• Main Authors: Badu-Mensah, Agnes, Guo, Xiufang, McAleer, Christopher W, Rumsey, John W, Hickman, James J
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 31.08.2020; Nature Publishing Group UK
• Subjects: Amyotrophic lateral sclerosis; Amyotrophic Lateral Sclerosis - etiology; Amyotrophic Lateral Sclerosis - genetics; Amyotrophic Lateral Sclerosis - pathology; Biopsy; Cell Lineage - genetics; Disease Progression; Humans; Induced Pluripotent Stem Cells - enzymology; Induced Pluripotent Stem Cells - metabolism; Membrane potential; Metabolism; Mitochondria; Mitochondria, Muscle - metabolism; Muscle contraction; Muscle Fibers, Skeletal - enzymology; Muscle Fibers, Skeletal - metabolism; Muscle Fibers, Skeletal - pathology; Muscle, Skeletal - pathology; Musculoskeletal system; Mutation - genetics; Myoblasts; Myoblasts - enzymology; Myoblasts - pathology; Myosin; Myotubes; Neuromuscular junctions; Pluripotency; Skeletal muscle; Stem cells; Superoxide dismutase; Superoxide Dismutase-1 - genetics; Toxicity
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-70510-3

Recent findings suggest a pathologic role of skeletal muscle in amyotrophic lateral sclerosis (ALS) onset and progression. However, the exact mechanism by which this occurs remains elusive due to limited human-based studies. To this end, phenotypic ALS skeletal muscle models were developed from induced pluripotent stem cells (iPSCs) derived from healthy individuals (WT) and ALS patients harboring mutations in the superoxide dismutase 1 (SOD1) gene. Although proliferative, SOD1 myoblasts demonstrated delayed and reduced fusion efficiency compared to WT. Additionally, SOD1 myotubes exhibited significantly reduced length and cross-section. Also, SOD1 myotubes had loosely arranged myosin heavy chain and reduced acetylcholine receptor expression per immunocytochemical analysis. Functional analysis indicated considerably reduced contractile force and synchrony in SOD1 myotubes. Mitochondrial assessment indicated reduced inner mitochondrial membrane potential (ΔΨm) and metabolic plasticity in the SOD1-iPSC derived myotubes. This work presents the first well-characterized in vitro iPSC-derived muscle model that demonstrates SOD1 toxicity effects on human muscle regeneration, contractility and metabolic function in ALS. Current findings align with previous ALS patient biopsy studies and suggest an active contribution of skeletal muscle in NMJ dysfunction. Further, the results validate this model as a human-relevant platform for ALS research and drug discovery studies.